KRAS and lung carcinoma: HIF1A-As2 silencing dramatically reduced cell proliferation and clonogenic ability in several lung cancer cells carrying KRAS amplification or mutation, but not in normal lung cell lines (Fig. 2B–D, Supplementary Fig. 2D).